SCHEMBL3345812

SCHEMBL3345812

COC(=O)c1cc(Br)cnc1OCCc1ccncc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 4/20 0.42
CNR2 P34972 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.40
KDR P35968 1/20 0.40
SLC2A1 P11166 1/20 0.40
HTT P42858 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3448577 0.88 TSHR (0.44) PIM1PIM2HSD17B10ALDH1A1CNR2
SCHEMBL3346064 0.86 PIM1 (0.51) PIM1PIM2CNR2KDRSLC2A1
SCHEMBL3344574 0.83 ALDH1A1 (0.40) PIM1PIM2HSD17B10ALDH1A1KDM4E
SCHEMBL3447564 0.80 OPRK1 (0.48) HSD17B10CNR2MAPK1OPRK1
SCHEMBL3348625 0.80 CNR2 (0.50) HSD17B10CNR2MAPK1OPRK1
SCHEMBL25175693 0.80 KDR (0.49) HSD17B10ALDH1A1KDM4EGLAGAA
SCHEMBL31481547 0.79 CNR2 (0.46) HSD17B10CNR2MAPK1OPRK1
SCHEMBL3348530 0.78 DGAT1 (0.40) PIM1PIM2HSD17B10ALDH1A1KDM4E
SCHEMBL16828719 0.76 LMNA (0.49) HSD17B10ALDH1A1KDM4EGAAMAPK1
SCHEMBL21513341 0.76 CNR2 (0.46) ALDH1A1CNR2KDM4ECYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010038081-A2 HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2010-04-08 WO disclosed